Orange Book product · Generic (ANDA)
PIPERAZINE CITRATE
PIPERAZINE CITRATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
PIPERAZINE CITRATE
Strength
EQ 500MG BASE/5ML
Dosage form
SYRUP
Route
ORAL
TE code
Not listed
Application
ANDA 080774
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PIPERAZINE CITRATE
- —ANTEPARBrand (NDA)
NDA 009102 · GLAXOSMITHKLINE
- —BRYRELBrand (NDA)
NDA 017796 · SANOFI AVENTIS US
- —MULTIFUGEBrand (NDA)
NDA 009452 · BLULINE
- —PIPERAZINE CITRATEGeneric (ANDA)
ANDA 080963 · LANNETT
- —PIPERAZINE CITRATEGeneric (ANDA)
ANDA 080671 · LUITPOLD
- —VERMIDOLGeneric (ANDA)
ANDA 080992 · SOLVAY
- —PIPERAZINE CITRATEGeneric (ANDA)
ANDA 080874 · IMPAX LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
